Publication Date
| In 2024 | 0 |
| Since 2023 | 0 |
| Since 2020 (last 5 years) | 0 |
| Since 2015 (last 10 years) | 0 |
| Since 2005 (last 20 years) | 1 |
Descriptor
| Adolescents | 1 |
| Drug Therapy | 1 |
| Eating Disorders | 1 |
| Females | 1 |
| Outcomes of Treatment | 1 |
| Pilot Projects | 1 |
| Young Adults | 1 |
Source
| Journal of the American… | 1 |
Author
| Dodge, Mindy | 1 |
| Ellert, Swan | 1 |
| Frank, Guido | 1 |
| Gardner, Rick | 1 |
| Gralla, Jane | 1 |
| Hagman, Jennifer | 1 |
| O'Lonergan, Teri | 1 |
| Sigel, Eric | 1 |
| Wamboldt, Marianne Z. | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Eating Disorder Inventory | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkHagman, Jennifer; Gralla, Jane; Sigel, Eric; Ellert, Swan; Dodge, Mindy; Gardner, Rick; O'Lonergan, Teri; Frank, Guido; Wamboldt, Marianne Z. – Journal of the American Academy of Child & Adolescent Psychiatry, 2011
Objective: The purpose of this double-blind, placebo-controlled exploratory pilot study was to evaluate the safety and efficacy of risperidone for the treatment of anorexia nervosa. Method: Forty female subjects 12 to 21 years of age (mean, 16 years) with primary anorexia nervosa in an eating disorders program were randomized to receive…
Descriptors: Eating Disorders, Drug Therapy, Young Adults, Adolescents
